The Bionics Institute is focused on delivering clinical outcomes and real-world applications in response to the health needs of the community, while providing fundamental knowledge to underpin new advances in medical bionics.
Our work strengthens the Australian economy through innovation and skills training for the next generation of researchers.
The Institute has:
Proven experience in taking research concepts through to readiness for real-world product development
Experience working in multidisciplinary teams and in collaboration with other organisations spanning medical, science and engineering fields
Expertise in neuroscience and electrophysiology research at both the in vitro and in vivo levels
Established infection control, biocompatibility and biological safety techniques which can be applied to all implant devices
Experience in important clinical research techniques including; signal processing, mathematical modelling, neurophysiology, behavioural performance measures for adults and children, and psychophysics
Our commercial arm
Bionic Enterprises was established in 2011 to provide the pathway for translating the Institute's neurobionics research program into real-world applications. Bionic Enterprises is committed to fast tracking development and reducing the cost of bringing new, safe and effective medical device products to the market within the next five years. These devices will treat a range of disabling neurological conditions including severe chronic pain, epilepsy and certain psychiatric and movement disorders.
The company is focused on devices that meet a clear clinical need and address a gap in the market. Most conditions are of relatively high incidence with 10-30% of sufferers poorly treated with existing treatments.
The Institute has facilitated the formation of two companies in the last ten years: